Finkelstein Thompson LLP Announces Investigation of Emergency Medical Services Corp.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Emergency Medical Services Corp. (“EMS” or the “Company”) (NYSE: EMS) concerning the proposed acquisition of the Company by an affiliate of the private equity firm Clayton Dubilier & Rice, LLC. Under the terms of the offer, EMS shareholders will receive $64.00 in cash for each share of Class A common stock, Class B common stock and LP Exchangeable Units they own. The transaction is valued at approximately $3.2 billion including the assumption of debt, and is expected to close in the second quarter of 2011.

The investigation is focused on the potential unfairness of the consideration to EMS shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among EMS Board members. The offer price is a 9.4% discount to the Company’s trading price the day immediately preceding the announcement of the transaction, and according to Yahoo! Finance at least one analyst has set a target price of $76 for the Company’s shares. Moreover, the Company stated that its largest shareholder Onex Corp. and related affiliates, holders of EMS’s LP Exchangeable Units, have sufficient voting power to approve the deal, and that they have agreed to vote in favor of it.

If you are interested in discussing your rights as an EMS shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at [phone] or by email at [e-mail].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.